LINC02154 promotes cell cycle and mitochondrial function in oral squamous cell carcinoma
Cancer Science · 2025
DOI: 10.1111/cas.16379 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, 2025. Verfasst von Takeshi Niinuma und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology, Sapporo Medical University School of Medicine, Sapporo, Japan. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Mitochondria, Mouth Neoplasms, Squamous Cell Carcinoma of Head and Neck. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The Takeda Science Foundation, The Sapporo Jikeikai Tomoiki Foundation, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Long noncoding RNAs (lncRNAs) play pivotal roles in the development of human malignancies, though their involvement in oral squamous cell carcinoma (OSCC) remains incompletely understood. Using The Cancer Genome Atlas (TCGA) dataset, we analyzed expression of 7840 lncRNAs in primary head and neck squamous cell carcinoma (HNSCC) and found that upregulation of LINC02154 is associated with a poorer prognosis. LINC02154 knockdown in OSCC cell lines induced cell cycle arrest and apoptosis, and significantly attenuated tumor growth in vitro and in vivo. Notably, depletion of LINC02154 downregulated FOXM1, a master regulator of cell cycle‐related genes. RNA pulldown and mass spectrometry analyses identified a series of proteins that could potentially interact with LINC02154, including HNRNPK and LRPPRC. HNRNPK stabilizes FOXM1 expression by interacting with the 3′‐UTR of FOXM1 mRNA, which suggests LINC02154 and HNRNPK promote cell cycling by regulating FOXM1 expression. Additionally, LINC02154 positively regulates HNRNPK expression by inhibiting microRNAs targeting HNRPNK. Moreover, LINC02154 affects mitochondrial function by interacting with LRPPRC. Depletion of LINC02154 suppressed expression of mitochondrial genes, including MTCO1 and MTCO2, and inhibited mitochondrial respiratory function in OSCC cells. These results suggest that LINC02154 exerts its oncogenic effects by modulating the cell cycle and oxidative phosphorylation in OSCC, highlighting LINC02154 as a potential therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Biology, Sapporo Medical University School of Medicine, Sapporo, Japan.
- Department of Cellular Physiology and Signal Transduction, Sapporo Medical University School of Medicine, Sapporo, Japan.
- Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan.
- Department of Oral Surgery, Sapporo Medical University School of Medicine, Sapporo, Japan.
- Division of Cell Bank, Biomedical Research, Education and Instrumentation Center, Sapporo Medical University School of Medicine, Sapporo, Japan.
- Department of Otolaryngology - Head and Neck Surgery, Sapporo Medical University School of Medicine, Sapporo, Japan.
ORCID-Profile: Hiroshi Kitajima, Hiromu Suzuki
Förderung
- The Takeda Science Foundation
- The Sapporo Jikeikai Tomoiki Foundation
- Japan Society for the Promotion of Science
Zitieren
APA
Niinuma, T., Kitajima, H., Sato, T., Ogawa, T., Ishiguro, K., Kai, M., Yamamoto, E., Hatanaka, Y., Nojima, I., Toyota, M., Yorozu, A., Sekiguchi, S., Tohse, N., Furuhashi, M., Ohguro, H., Miyazaki, A., & Suzuki, H. (2025). LINC02154 promotes cell cycle and mitochondrial function in oral squamous cell carcinoma. Cancer Science. https://doi.org/10.1111/cas.16379
Vancouver
Niinuma T, Kitajima H, Sato T, Ogawa T, Ishiguro K, Kai M, et al. LINC02154 promotes cell cycle and mitochondrial function in oral squamous cell carcinoma. Cancer Science. 2025. doi:10.1111/cas.16379
BibTeX
@article{Niinuma2025,
author = {Niinuma, Takeshi and Kitajima, Hiroshi and Sato, Tatsuya and Ogawa, Toshifumi and Ishiguro, Kazuya and Kai, Masahiro and Yamamoto, Eiichiro and Hatanaka, Yui and Nojima, Iyori and Toyota, Mutsumi and Yorozu, Akira and Sekiguchi, Shohei and Tohse, Noritsugu and Furuhashi, Masato and Ohguro, Hiroshi and Miyazaki, Akihiro and Suzuki, Hiromu},
title = {LINC02154 promotes cell cycle and mitochondrial function in oral squamous cell carcinoma},
journal = {Cancer Science},
year = {2025},
doi = {10.1111/cas.16379}
}
EUVIMED